Attorney General DEA FDA federal prohibition pardons Politics President Biden rescheduling The Haymaker

President Biden’s marijuana ‘review’ could be a deadly trap

Pardoning 6,000 prisoners is a win. We’ll take it. But that “review” of marijuana’s Schedule I status could end in disaster.
The post President Biden’s marijuana ‘review’ could be a deadly trap appeared first on Leafly.

Cory Booker DEA Earl Blumenauer Marijuana Legislation Nancy Mace news psilocybin psychedelics Rand Paul

Congress: Two New Bills Would Pressure DEA To Allow Patient Access To Psychedelics And Weed

Congress: Two New Bills Would Pressure DEA To Allow Patient Access To Psychedelics And Weed
The measures would constitute a technical amendment to the original law’s text.
The post Congress: Two New Bills Would Pressure DEA To Allow Patient Access To P…

arrests DEA equality Marijuana Legislation news racial injustice

Federal Arrests For Marijuana Have Declined As More States Legalize It

Federal Arrests For Marijuana Have Declined As More States Legalize It
Cannabis busts dropped an average of 11% each year since 2010 when the DEA made 8,215 arrests.
The post Federal Arrests For Marijuana Have Declined As More States Legalize It appear…

cannabis DEA Huntington’s Disease labs medical marijuana multiple sclerosis news research Rhode Island

DEA Sued By Rhode Island Lab Over ‘Foot Dragging’ On Marijuana Pharmaceutical Licensing

DEA Sued By Rhode Island Lab Over ‘Foot Dragging’ On Marijuana Pharmaceutical Licensing
The president of the companies behind the lawsuit said they have taken “extreme” efforts to secure the licenses and comply with rigorous FDA guidelines….

DEA Huntington’s Disease medical marijuana multiple sclerosis news

DEA Delays Production Of Marijuana Drug As Potential Treatment For MS And Huntington’s Disease

DEA Delays Production Of Marijuana Drug As Potential Treatment For MS And Huntington’s Disease
The DEA application process is being delayed for years for reasons unknown.
The post DEA Delays Production Of Marijuana Drug As Potential Treatment For…

Cannabusiness Controlled Substances Act DEA Nora Volkow opinion schedule 1

How The Cannabis Industry Can Solve The Schedule-I Drug Research Barrier Problem

How The Cannabis Industry Can Solve The Schedule-I Drug Research Barrier Problem
Research is forbidden on Schedule I drugs in the U.S. — here’s how marijuana can get around that rule.
The post How The Cannabis Industry Can Solve The Schedule-I Drug Res…

cannabis DEA fentanyl GOP news nida psilocybin

GOP Lawmakers Introduce Bill To Streamline Cannabis Research After DEA Shows Support For White House Plan

GOP Lawmakers Introduce Bill To Streamline Cannabis Research After DEA Shows Support For White House Plan
Two GOP lawmakers introduced new legislation in the House and Senate poised to further streamline research of Schedule I drugs like marijuana.
The…